Intervention Review

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis

  1. Patricia M Fortin1,*,
  2. Aaron M Tejani2,
  3. Ken Bassett1,
  4. Vijaya M Musini1

Editorial Group: Cochrane Vascular Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 16 NOV 2012

DOI: 10.1002/14651858.CD007057.pub3


How to Cite

Fortin PM, Tejani AM, Bassett K, Musini VM. Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD007057. DOI: 10.1002/14651858.CD007057.pub3.

Author Information

  1. 1

    University of British Columbia, Department of Anesthesiology, Pharmacology and Therapeutics, Vancouver, BC, Canada

  2. 2

    University of British Columbia, Therapeutics Initiative, Vancouver, BC, Canada

*Patricia M Fortin, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada. patricia@ti.ubc.ca.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 31 JAN 2013

SEARCH

  1. Current Version

    Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis

    Patricia M Fortin, Aaron M Tejani, Ken Bassett and Vijaya M Musini

    Version of Record online: 31 JAN 2013 | DOI: 10.1002/14651858.CD007057.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis

    Patricia M Fortin, Aaron M Tejani, Ken Bassett and Vijaya M Musini

    Version of Record online: 8 JUL 2009 | DOI: 10.1002/14651858.CD007057.pub2

  2. Version 1

    Intravenous immunoglobulin for Wegener's granulomatosis

    Patricia M Fortin, Aaron Tejani, Ken Bassett and Vijaya M Musini

    Version of Record online: 23 APR 2008 | DOI: 10.1002/14651858.CD007057